Home › Funds › Millennium Management › ACXP
Millennium Management position in ACXP
ACURX PHARMACEUTICALS INC · Health Care
Latest position (Q4 2025)41.43K sh
Reported value held$103.15K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 30.09K | $155.00K | New |
| Q4 2021 | 13.95K | $61.00K | Reduce |
| Q3 2022 | 47.39K | $142.00K | New |
| Q4 2022 | 29.10K | $116 | Reduce |
| Q1 2023 | 22.05K | $76 | Reduce |
| Q2 2023 | 17.31K | $45.87K | Reduce |
| Q3 2023 | 14.57K | $20.84K | Reduce |
| Q4 2025 | 41.43K | $103.15K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ACXP
- Vanguard Group 23.28K sh · $57.97K · Q4 2025
- Geode Capital Management 26.41K sh · $40.94K · Q2 2026
- Morgan Stanley 7.50K sh · $11.62K · Q2 2026
- Wells Fargo & Co 2.30K sh · $3.56K · Q2 2026
- BlackRock Inc 60 sh · $93 · Q2 2026
- UBS Group AG 3 sh · $5 · Q2 2026